<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CrashDash ‚Ä¢ CNSL.L APEX Profile</title>
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { 
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            padding: 20px;
            color: #333;
        }
        .container { max-width: 1200px; margin: 0 auto; }
        
        .header-card {
            background: white;
            border-radius: 16px;
            padding: 30px;
            margin-bottom: 20px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }
        .ticker-badge {
            display: inline-block;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 8px 16px;
            border-radius: 20px;
            font-weight: bold;
            font-size: 18px;
            margin-bottom: 10px;
        }
        .company-name { font-size: 32px; font-weight: 700; margin-bottom: 8px; }
        .company-meta {
            display: flex;
            gap: 20px;
            margin-top: 15px;
            flex-wrap: wrap;
        }
        .meta-item {
            display: flex;
            align-items: center;
            gap: 8px;
            padding: 8px 16px;
            background: #f7fafc;
            border-radius: 8px;
            font-size: 14px;
        }
        .meta-icon { font-size: 18px; }
        
        .score-hero {
            background: linear-gradient(135deg, #f093fb 0%, #f5576c 100%);
            color: white;
            border-radius: 16px;
            padding: 40px;
            margin-bottom: 20px;
            text-align: center;
            box-shadow: 0 10px 40px rgba(0,0,0,0.15);
        }
        .action-display {
            margin-bottom: 20px;
        }
        .scores-row {
            display: flex;
            justify-content: center;
            gap: 40px;
            margin: 30px 0;
        }
        .score-circle {
            width: 140px;
            height: 140px;
            border-radius: 50%;
            background: white;
            display: flex;
            flex-direction: column;
            align-items: center;
            justify-content: center;
            box-shadow: 0 4px 15px rgba(0,0,0,0.1);
        }
        .score-number {
            font-size: 48px;
            font-weight: 800;
            line-height: 1;
        }
        .score-label { font-size: 12px; color: #666; margin-top: 5px; }
        .timing-badge-large {
            display: inline-block;
            padding: 15px 40px;
            border-radius: 30px;
            font-weight: 700;
            font-size: 24px;
            background: rgba(255,255,255,0.2);
            backdrop-filter: blur(10px);
            color: white;
            margin: 20px 0;
        }
        .thesis-line {
            font-size: 18px;
            font-weight: 600;
            color: white;
            background: rgba(255,255,255,0.15);
            backdrop-filter: blur(10px);
            padding: 20px;
            border-radius: 12px;
            margin-top: 20px;
        }
        
        .factors-list {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 15px;
            margin-top: 20px;
        }
        .factor-item {
            background: white;
            padding: 15px;
            border-radius: 12px;
            display: flex;
            align-items: center;
            gap: 10px;
            font-size: 14px;
        }
        .factor-icon { font-size: 20px; }
        
        .cards-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
            margin-bottom: 20px;
        }
        .card {
            background: white;
            border-radius: 16px;
            padding: 25px;
            box-shadow: 0 4px 20px rgba(0,0,0,0.08);
        }
        .card-title {
            font-size: 18px;
            font-weight: 600;
            margin-bottom: 20px;
            display: flex;
            align-items: center;
            gap: 10px;
        }
        .card-icon { font-size: 24px; }
        
        .stat-row {
            display: flex;
            justify-content: space-between;
            padding: 12px 0;
            border-bottom: 1px solid #f0f0f0;
        }
        .stat-row:last-child { border-bottom: none; }
        .stat-label { color: #666; font-size: 14px; }
        .stat-value { font-weight: 600; font-size: 16px; }
        
        .rally-badge {
            display: inline-block;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 12px;
            font-weight: 600;
            text-transform: uppercase;
        }
        
        .risk-indicator {
            display: flex;
            align-items: center;
            gap: 15px;
            padding: 15px;
            border-radius: 12px;
            margin-bottom: 10px;
        }
        .risk-high { background: #fee2e2; }
        .risk-icon { font-size: 24px; }
        
        .reason-item {
            padding: 15px;
            background: #f9fafb;
            border-radius: 8px;
            margin-bottom: 12px;
        }
        
        .tag {
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 11px;
            font-weight: 600;
        }
        
        .footer {
            background: white;
            border-radius: 16px;
            padding: 20px;
            text-align: center;
            color: #666;
            font-size: 13px;
            box-shadow: 0 4px 20px rgba(0,0,0,0.08);
            margin-top: 20px;
        }
        
        .alert-box {
            background: #fef3c7;
            border-left: 4px solid #f59e0b;
            padding: 15px;
            border-radius: 8px;
            margin: 15px 0;
        }
    </style>
</head>
<body>
    <div class="container">
        
        <!-- Header Card -->
        <div class="header-card">
            <div class="ticker-badge">CNSL.L</div>
            <div class="company-name">Cambridge Nutritional Sciences plc</div>
            <div class="company-meta">
                <div class="meta-item">
                    <span class="meta-icon">‚ñ†</span>
                    <span><strong>Sector:</strong> Healthcare</span>
                </div>
                <div class="meta-item">
                    <span class="meta-icon">¬£</span>
                    <span><strong>Market Cap:</strong> ¬£5,472,865</span>
                </div>
                <div class="meta-item">
                    <span class="meta-icon">‚ó∑</span>
                    <span><strong>Days Active:</strong> 1226 days</span>
                </div>
            </div>
        </div>

        <!-- Action & Score Hero Section -->
        <div class="score-hero">
            <div class="action-display">
                <span style="font-size: 32px; font-weight: 800; color: white;">‚óâ WATCH</span>
            </div>
            
            <div class="scores-row">
                <div class="score-circle">
                    <div class="score-number" style="color: #f59e0b;">67</div>
                    <div class="score-label">APEX SCORE</div>
                </div>
                <div class="score-circle">
                    <div class="score-number" style="color: #f59e0b;">50</div>
                    <div class="score-label">CONFIDENCE</div>
                </div>
            </div>
            
            <div class="timing-badge-large">
                Timing: <span class="rally-badge" style="background: #fee2e2; color: #991b1b;">TOO EARLY</span>
            </div>
            
            <div class="thesis-line">
                WATCH - TOO_EARLY timing with 67/100 opportunity score
            </div>
        </div>

        <!-- ==================== AI TRADER INTELLIGENCE (TOP) - TRADER BRIEF V2 ==================== -->
        

        <!-- Decision Summary -->
        <div class="card">
            <div class="card-title">
                <span class="card-icon">‚óÜ</span>
                Why This Matters
            </div>
            <div class="stat-row"><span>‚Ä¢ APEX 67/100 indicates strong opportunity quality</span></div><div class="stat-row"><span>‚Ä¢ Timing regime: TOO_EARLY</span></div><div class="stat-row"><span>‚Ä¢ Historical profile: 6 rallies, 71% best run</span></div>
            
            <div class="alert-box" style="margin-top: 20px;">
                <strong>‚ñ≥ Main Risk:</strong> Confidence 50/100 - full data loaded
            </div>
            
            <div style="margin-top: 20px;">
                <strong>‚óâ Watch Next:</strong>
                <div style="padding: 8px 0;">‚Ä¢ RNS catalysts (funding/operational updates)</div><div style="padding: 8px 0;">‚Ä¢ Volume expansion confirmation</div><div style="padding: 8px 0;">‚Ä¢ Timing regime change signals</div>
            </div>
        </div>

        <!-- ==================== TECHNICAL DETAILS (COLLAPSIBLE) ==================== -->
        
        <div class="card">
          <details style="cursor:pointer;">
            <summary style="font-weight:800; font-size:16px; list-style:none; padding: 10px; background: #f9fafb; border-radius: 8px;">
              üîß Technical Analysis & Scoring Details
            </summary>
            <div style="margin-top:14px;">
              
            <!-- Scoring Breakdown -->
            <div class="card-title" style="margin-top: 20px;">
                <span class="card-icon">‚ñ£</span>
                APEX Score Breakdown
            </div>
            <div class="factors-list">
                <div class="factor-item"><span class="factor-icon">‚óÜ</span><span><strong>Strong Technical Setup</strong><br><small>Chart quality: 12/20 ‚Ä¢ Score: 15/25 points</small></span></div>
<div class="factor-item"><span class="factor-icon">‚óÜ</span><span><strong>Massive recovery potential</strong><br><small>Down 95.7% from peak ‚Ä¢ Score: 19/20 points</small></span></div>
<div class="factor-item"><span class="factor-icon">‚óÜ</span><span><strong>Strong volume</strong><br><small>2.6x average ‚Ä¢ Score: 10/10 points</small></span></div>
<div class="factor-item"><span class="factor-icon">‚óÜ</span><span><strong>Proven winner</strong><br><small>6 previous rallies ‚Ä¢ Score: 15/15 points</small></span></div>
<div class="factor-item"><span class="factor-icon">‚óÜ</span><span><strong>Modest upside</strong><br><small>Historical best: +71% ‚Ä¢ Score: 8/20 points</small></span></div>

            </div>
            
            <div style="margin-top: 40px;"></div>
            
            <!-- Exhaustion Metrics -->
            <div class="card-title">
                <span class="card-icon">üìà</span>
                Rally Cycle Position
            </div>
            <div style="display: grid; grid-template-columns: repeat(auto-fit, minmax(150px, 1fr)); gap: 15px; margin: 20px 0;">
                <div style="padding: 15px; background: linear-gradient(135deg, #10b981 0%, #059669 100%); border-radius: 8px; text-align: center; color: white;">
                    <div style="font-size: 12px; opacity: 0.9; margin-bottom: 5px;">Current Position</div>
                    <div style="font-size: 32px; font-weight: 800;">-10%</div>
                    <div style="font-size: 11px; opacity: 0.8;">from entry</div>
                </div>
                <div style="padding: 15px; background: linear-gradient(135deg, #3b82f6 0%, #1d4ed8 100%); border-radius: 8px; text-align: center; color: white;">
                    <div style="font-size: 12px; opacity: 0.9; margin-bottom: 5px;">Typical Rally</div>
                    <div style="font-size: 32px; font-weight: 800;">71%</div>
                    <div style="font-size: 11px; opacity: 0.8;">historical avg</div>
                </div>
                <div style="padding: 15px; background: linear-gradient(135deg, #f59e0b 0%, #d97706 100%); border-radius: 8px; text-align: center; color: white;">
                    <div style="font-size: 12px; opacity: 0.9; margin-bottom: 5px;">Exhaustion Level</div>
                    <div style="font-size: 32px; font-weight: 800;">-0.1x</div>
                    <div style="font-size: 11px; opacity: 0.8;">vs average</div>
                </div>
            </div>
        
            </div>
          </details>
        </div>
        

        <!-- Reasons Buy/Sell -->
        <div class="cards-grid">
            <div class="card">
                <div class="card-title">
                    <span class="card-icon" style="color: #10b981;">‚ñ≤</span>
                    Reasons to Buy
                </div>
                
            <div class="reason-item">
                <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 8px;">
                    <span style="font-weight: 600;">Early stage positioning offers best R:R if catalysts appear</span>
                    <span class="tag" style="background: #f59e0b; color: white;">‚ö° Medium Strength</span>
                </div>
                <div style="font-size: 12px; color: #666;">timing=TOO EARLY ‚Ä¢ current return=-9.8%</div>
            </div>
            
            <div class="reason-item">
                <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 8px;">
                    <span style="font-weight: 600;">Proven winner - previously hit lock-in target</span>
                    <span class="tag" style="background: #f59e0b; color: white;">‚ö° Medium Strength</span>
                </div>
                <div style="font-size: 12px; color: #666;">profit target reached: True</div>
            </div>
            
            </div>
            
            <div class="card">
                <div class="card-title">
                    <span class="card-icon" style="color: #ef4444;">‚ñº</span>
                    Reasons to Sell / Avoid
                </div>
                
            <div class="reason-item">
                <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 8px;">
                    <span style="font-weight: 600;">Triangulation not loaded (RNS/social/trends missing)</span>
                    <span class="tag" style="background: #ef4444; color: white;">üö® High Risk</span>
                </div>
                <div style="font-size: 12px; color: #666;">HISTORICAL ONLY ‚Ä¢ confidence capped at 65</div>
            </div>
            
            <div class="reason-item">
                <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 8px;">
                    <span style="font-weight: 600;">Stale signal - not for active trading</span>
                    <span class="tag" style="background: #ef4444; color: white;">üö® High Risk</span>
                </div>
                <div style="font-size: 12px; color: #666;">historical</div>
            </div>
            
            </div>
        </div>

        <!-- Trade Plans -->
        <div class="cards-grid">
            <div class="card">
                <div class="card-title">
                    <span class="card-icon">üìä</span>
                    Short-Term Trader Playbook
                </div>
                <div style="background: linear-gradient(135deg, #f093fb 0%, #f5576c 20%); color: white; padding: 15px; border-radius: 8px; margin-bottom: 15px;">
                    <div style="font-size: 18px; font-weight: 600; margin-bottom: 5px;">Watch / Starter</div>
                    <div style="font-size: 14px; opacity: 0.9;">Wait for base + catalyst confirmation; starter position only</div>
                </div>
                <div style="padding: 12px; background: #f9fafb; border-radius: 6px; margin-bottom: 10px;">
                    <div style="font-size: 12px; color: #666; margin-bottom: 3px;">Position Size</div>
                    <div style="font-weight: 600;">0-1% until CONFIRMED</div>
                </div>
                <div style="padding: 12px; background: #fef2f2; border-radius: 6px; margin-bottom: 10px;">
                    <div style="font-size: 12px; color: #666; margin-bottom: 3px;">Risk Management</div>
                    <div style="font-weight: 600; color: #dc2626;">Invalidation = breaks recent lows / dilution / suspension</div>
                </div>
                <div style="padding: 12px; background: #f0fdf4; border-radius: 6px;">
                    <div style="font-size: 12px; color: #666; margin-bottom: 3px;">Exit Strategy</div>
                    <div style="font-weight: 600; color: #059669;">Scale out 25% at +15%, 25% at +50%, runner above</div>
                </div>
            </div>
            
            <div class="card">
                <div class="card-title">
                    <span class="card-icon">üíº</span>
                    Long-Term Investor Playbook
                </div>
                <div style="background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); color: white; padding: 15px; border-radius: 8px; margin-bottom: 15px; text-align: center;">
                    <div style="font-size: 32px; margin-bottom: 5px;">‚úó</div>
                    <div style="font-size: 18px; font-weight: 600;">Not Recommended for Investors</div>
                </div>
                <div style="padding: 15px; background: #f9fafb; border-radius: 8px; font-size: 14px; line-height: 1.6;">
                    <strong style="color: #667eea;">üìã Investment Thesis:</strong><br>
                    Unlock after AI triangulation + CONFIRMED timing<br><br>
                    <strong style="color: #667eea;">‚è≥ Time Horizon:</strong><br>
                    N/A<br><br>
                    <strong style="color: #ef4444;">üõ°Ô∏è Exit Rule:</strong><br>
                    N/A
                </div>
            </div>
        </div>

        <!-- Commentary -->
        <div class="card">
            <div class="card-title">
                <span class="card-icon">‚óê</span>
                Executive Commentary
            </div>
            <div style="line-height: 1.6; margin-bottom: 20px;">
                This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows TOO_EARLY timing with 67/100 APEX score. Historical data shows 6 rallies averaging 71% upside. Current position: -9.8%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.
            </div>
            
            <div style="margin-top: 20px;">
                <strong style="color: #10b981;">‚ñ≤ Bull Case:</strong>
                <div style="padding: 8px 0;">‚Ä¢ Reliable pattern (6 previous rallies)</div><div style="padding: 8px 0;">‚Ä¢ Early regime often offers best risk/reward</div>
            </div>
            
            <div style="margin-top: 20px;">
                <strong style="color: #ef4444;">‚ñº Bear Case:</strong>
                <div style="padding: 8px 0;">‚Ä¢ TOO_EARLY means you can get chopped before real move</div>
            </div>
            
            <div style="margin-top: 20px; padding: 15px; background: #f0f9ff; border-radius: 8px;">
                <strong>‚ó∑ Timing Translation:</strong><br>
                It might be starting, but not proven yet. Wait for base + volume + catalysts.
            </div>
            
            <div style="margin-top: 20px; padding: 15px; background: #fef3c7; border-radius: 8px;">
                <strong>‚óé Confidence Explained:</strong><br>
                Confidence 50/100 reflects full data quality with triangulation loaded.
            </div>
        </div>

        <!-- Data Quality Warning -->
        <div class="card">
            <div class="card-title">
                <span class="card-icon">‚ñ≥</span>
                Data Quality Notice
            </div>
            <div class="alert-box">
                <strong>Analysis Mode:</strong> HISTORICAL_ONLY<br>
                <strong>Impact:</strong> HIGH
            </div>
            <div class="risk-indicator risk-high"><span class="risk-icon">‚ñ≥</span><div><div style="font-weight: 600;">AI insights from Groq LLM</div></div></div>

            <div style="margin-top: 15px; font-size: 13px; color: #666;">
                Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk.
            </div>
        </div>

        <!-- ==================== TOP 5 RECENT RNS NEWS ==================== -->
        
        <div class="card" style="border-top: 3px solid #3b82f6;">
            <div class="card-title" style="margin-bottom: 20px;">
                <span class="card-icon">üì∞</span>
                Top 5 Recent RNS Announcements
            </div>
            <div style="margin-top: 15px;">
                
            <div style="
                margin-bottom: 20px;
                padding: 18px;
                background: white;
                border-radius: 14px;
                border: 1px solid #e2e8f0;
                box-shadow: 0 1px 3px rgba(0,0,0,0.05);
            ">
                <div style="display: flex; align-items: center; gap: 10px; margin-bottom: 14px;">
                    <span style="
                        display: inline-flex;
                        align-items: center;
                        justify-content: center;
                        width: 30px;
                        height: 30px;
                        background: linear-gradient(135deg, #10b981 0%, #10b981dd 100%);
                        color: white;
                        border-radius: 50%;
                        font-weight: 800;
                        font-size: 15px;
                        box-shadow: 0 2px 8px #10b98140;
                    ">1</span>
                    <div style="font-size: 11px; color: #94a3b8; font-weight: 600; letter-spacing: 0.5px;">
                        RNS ANNOUNCEMENT #1
                    </div>
                </div>
                
                
            <div style="
                background: linear-gradient(135deg, #10b981 0%, #10b981dd 100%);
                color: white;
                padding: 14px;
                border-radius: 10px;
                margin-bottom: 16px;
            ">
                <div style="display: flex; align-items: center; gap: 10px; margin-bottom: 8px;">
                    <span style="font-size: 20px;">üìà</span>
                    <div style="flex: 1;">
                        <div style="font-weight: 700; font-size: 16px;">Director/PDMR Shareholding</div>
                        <span style="
                            display: inline-block;
                            background: rgba(255,255,255,0.25);
                            padding: 2px 10px;
                            border-radius: 12px;
                            font-size: 11px;
                            margin-top: 4px;
                            font-weight: 600;
                        ">GROK: 100/100 ‚Ä¢ BULLISH</span>
                    </div>
                </div>
                <div style="font-size: 13px; opacity: 0.95; line-height: 1.4;">
                    INSIDER TRANSACTION: INSIDER BUYING - 97,500 shares @ 30p (confidence signal) | ‚úÖ BULLISH: Insiders buying = confidence in company value. Often precedes price rises.
                </div>
            </div>
            
                
            <div style="
                display: grid;
                grid-template-columns: repeat(auto-fit, minmax(120px, 1fr));
                gap: 10px;
                margin: 16px 0;
            ">
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">DATE</div>
                    <div style="font-weight: 700; font-size: 13px; color: #0f172a;">30th Jan 2025</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">TIME</div>
                    <div style="font-weight: 700; font-size: 13px; color: #0f172a;">9:41 am</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">SOURCE</div>
                    <div style="font-weight: 700; font-size: 13px; color: #10b981;">RNS</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">SENTIMENT</div>
                    <div style="font-weight: 700; font-size: 13px; color: #10b981;">BULLISH</div>
                </div>
            </div>
            
                
                <div style="
                    margin: 16px 0;
                    padding: 14px;
                    background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
                    border-radius: 10px;
                    border-left: 4px solid #10b981;
                ">
                    <h4 style="
                        font-size: 13px;
                        color: #1e293b;
                        margin-bottom: 12px;
                        font-weight: 700;
                        display: flex;
                        align-items: center;
                        gap: 8px;
                    ">
                        <span style="font-size: 16px;">ü§ñ</span> GROK INTELLIGENCE ANALYSIS
                        <span style="
                            display: inline-block;
                            background: #10b981;
                            color: white;
                            padding: 2px 8px;
                            border-radius: 10px;
                            font-size: 11px;
                            font-weight: 800;
                        ">100/100</span>
                    </h4>
                    
                    <div style="display: grid; gap: 10px;">
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">EVENT TYPE:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">INSIDER TRANSACTION: INSIDER BUYING - 97,500 shares @ 30p (confidence signal)</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">TRADING VIEW:</div>
                            <div style="font-size: 12px; color: #10b981; font-weight: 600;">‚úÖ BULLISH: Insiders buying = confidence in company value. Often precedes price rises.</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">RISK LEVEL:</div>
                            <div style="font-size: 12px; color: #3b82f6; font-weight: 600;">üîµ NEUTRAL: Balanced or routine update</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">RECOMMENDED:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">üìä ANALYZE: Determine offer price, arbitrage opportunity if discount</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">COMPANY HEALTH:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">‚û°Ô∏è STABLE: Mixed signals, normal operations</div>
                        </div>
                    </div>
                </div>
                
                
                    <div style="margin: 16px 0;">
                        <h4 style="font-size: 14px; color: #1e293b; margin-bottom: 10px; font-weight: 700;">üìä Key Data Points:</h4>
                        <table style="width: 100%; border-collapse: collapse; font-size: 13px; background: white; border-radius: 8px; overflow: hidden;">
                            
                    <tr style="border-bottom: 1px solid #e2e8f0;">
                        <td style="padding: 8px; color: #64748b; font-weight: 600; font-size: 12px;">PERSON/ENTITY:</td>
                        <td style="padding: 8px; font-weight: 600; font-size: 12px;">Primary Information</td>
                    </tr>
                    
                        <tr style="border-bottom: 1px solid #e2e8f0;">
                            <td style="padding: 8px; color: #64748b; font-weight: 600; font-size: 12px;">ACTION:</td>
                            <td style="padding: 8px; font-weight: 600; font-size: 12px; color: #10b981;">PURCHASE</td>
                        </tr>
                        
                    <tr style="border-bottom: 1px solid #e2e8f0;">
                        <td style="padding: 8px; color: #64748b; font-weight: 600; font-size: 12px;">KEY METRICS:</td>
                        <td style="padding: 8px; font-weight: 600; font-size: 12px;">0.04%</td>
                    </tr>
                    
                        </table>
                    </div>
                    
                
            <details style="margin-top: 16px;">
                <summary style="
                    padding: 10px;
                    background: #f8fafc;
                    border-radius: 8px;
                    font-weight: 600;
                    font-size: 12px;
                    list-style: none;
                    cursor: pointer;
                    color: #64748b;
                    border: 1px solid #e2e8f0;
                ">
                    üìÑ View Full RNS Text
                </summary>
                <div style="
                    margin-top: 8px;
                    padding: 14px;
                    background: #f1f5f9;
                    border-radius: 8px;
                    font-family: 'Courier New', monospace;
                    font-size: 11px;
                    line-height: 1.5;
                    color: #475569;
                    max-height: 300px;
                    overflow-y: auto;
                    white-space: pre-wrap;
                    word-wrap: break-word;
                ">
30 Jan 2025 09:41
RNS Number : 2943V
Cambridge Nutritional Sciences PLC
30 January 2025
Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Director/PDMR Shareholding
CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition,
announces that it has received notification that Carolyn Rand, Non-Executive Chair of the Company, has purchased 97,500 ordinary shares of 4 pence each in the Company ("
Ordinary Shares
") on 29 January 2025, at a price of 3.668 pence each.
A summary of Carolyn Rand's resultant holdings is below:
Director
Board Position
Number of Ordinary Shares acquired
Total beneficial holding of Ordinary Shares following this acquisition
Number of Ordinary Shares
Approximate % of Company's issued share capital
Carolyn Rand
Non-Executive Chair
97,500
97,500
0.04%
Contacts:
Cambridge Nutritional Sciences plc
www.cnsplc.com
Carolyn Rand, Non-Executive Chair
James Cooper, Interim Chief Executive
Cavendish Capital Markets Limited
Tel: 020 7220 0500
Geoff Nash / Edward Whiley (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist
medical diagnostics company focused on industry-leading Health and Nutrition products.
Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Carolyn Rand
2
Reason for the notification
a)
Position/status
Non-Executive Chair
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Cambridge Nutritional Sciences plc
b)
LEI
2138007U9P4BTZTYIR92
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 4 pence each
ISIN: GB00B1VCP282
b)
Nature of the transaction
Ordinary Shares purchased
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3.668 pence
97,500
d)
Aggregated information
-Aggregated volume
- Price
See above
e)
Date of the transaction
29.01.2025
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com
or visit
www.rns.com
.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy
.
END
DSHGCGDBLXXDGUG
                </div>
            </details>
            
            </div>
            
            <div style="
                margin-bottom: 20px;
                padding: 18px;
                background: white;
                border-radius: 14px;
                border: 1px solid #e2e8f0;
                box-shadow: 0 1px 3px rgba(0,0,0,0.05);
            ">
                <div style="display: flex; align-items: center; gap: 10px; margin-bottom: 14px;">
                    <span style="
                        display: inline-flex;
                        align-items: center;
                        justify-content: center;
                        width: 30px;
                        height: 30px;
                        background: linear-gradient(135deg, #3b82f6 0%, #3b82f6dd 100%);
                        color: white;
                        border-radius: 50%;
                        font-weight: 800;
                        font-size: 15px;
                        box-shadow: 0 2px 8px #3b82f640;
                    ">2</span>
                    <div style="font-size: 11px; color: #94a3b8; font-weight: 600; letter-spacing: 0.5px;">
                        RNS ANNOUNCEMENT #2
                    </div>
                </div>
                
                
            <div style="
                background: linear-gradient(135deg, #3b82f6 0%, #3b82f6dd 100%);
                color: white;
                padding: 14px;
                border-radius: 10px;
                margin-bottom: 16px;
            ">
                <div style="display: flex; align-items: center; gap: 10px; margin-bottom: 8px;">
                    <span style="font-size: 20px;">üìä</span>
                    <div style="flex: 1;">
                        <div style="font-weight: 700; font-size: 16px;">Half-year Report</div>
                        <span style="
                            display: inline-block;
                            background: rgba(255,255,255,0.25);
                            padding: 2px 10px;
                            border-radius: 12px;
                            font-size: 11px;
                            margin-top: 4px;
                            font-weight: 600;
                        ">GROK: 90/100 ‚Ä¢ NEUTRAL</span>
                    </div>
                </div>
                <div style="font-size: 13px; opacity: 0.95; line-height: 1.4;">
                    CORPORATE NEWS: Half-year Report | üìä Neutral informational update
                </div>
            </div>
            
                
            <div style="
                display: grid;
                grid-template-columns: repeat(auto-fit, minmax(120px, 1fr));
                gap: 10px;
                margin: 16px 0;
            ">
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">DATE</div>
                    <div style="font-weight: 700; font-size: 13px; color: #0f172a;">23rd Nov 2023</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">TIME</div>
                    <div style="font-weight: 700; font-size: 13px; color: #0f172a;">7:00 am</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">SOURCE</div>
                    <div style="font-weight: 700; font-size: 13px; color: #3b82f6;">RNS</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">SENTIMENT</div>
                    <div style="font-weight: 700; font-size: 13px; color: #3b82f6;">NEUTRAL</div>
                </div>
            </div>
            
                
                <div style="
                    margin: 16px 0;
                    padding: 14px;
                    background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
                    border-radius: 10px;
                    border-left: 4px solid #3b82f6;
                ">
                    <h4 style="
                        font-size: 13px;
                        color: #1e293b;
                        margin-bottom: 12px;
                        font-weight: 700;
                        display: flex;
                        align-items: center;
                        gap: 8px;
                    ">
                        <span style="font-size: 16px;">ü§ñ</span> GROK INTELLIGENCE ANALYSIS
                        <span style="
                            display: inline-block;
                            background: #3b82f6;
                            color: white;
                            padding: 2px 8px;
                            border-radius: 10px;
                            font-size: 11px;
                            font-weight: 800;
                        ">90/100</span>
                    </h4>
                    
                    <div style="display: grid; gap: 10px;">
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">EVENT TYPE:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">CORPORATE NEWS: Half-year Report</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">TRADING VIEW:</div>
                            <div style="font-size: 12px; color: #3b82f6; font-weight: 600;">üìä Neutral informational update</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">RISK LEVEL:</div>
                            <div style="font-size: 12px; color: #3b82f6; font-weight: 600;">üîµ NEUTRAL: Balanced or routine update</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">RECOMMENDED:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">üìã HOLD: Monitor for developing patterns in announcements</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">COMPANY HEALTH:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">‚û°Ô∏è STABLE: Mixed signals, normal operations</div>
                        </div>
                    </div>
                </div>
                
                
                    <div style="margin: 16px 0;">
                        <h4 style="font-size: 14px; color: #1e293b; margin-bottom: 10px; font-weight: 700;">üìä Key Data Points:</h4>
                        <table style="width: 100%; border-collapse: collapse; font-size: 13px; background: white; border-radius: 8px; overflow: hidden;">
                            
                    <tr style="border-bottom: 1px solid #e2e8f0;">
                        <td style="padding: 8px; color: #64748b; font-weight: 600; font-size: 12px;">PERSON/ENTITY:</td>
                        <td style="padding: 8px; font-weight: 600; font-size: 12px;">Primary Information</td>
                    </tr>
                    
                    <tr style="border-bottom: 1px solid #e2e8f0;">
                        <td style="padding: 8px; color: #64748b; font-weight: 600; font-size: 12px;">KEY METRICS:</td>
                        <td style="padding: 8px; font-weight: 600; font-size: 12px;">44%, 62.7%, 54.0%</td>
                    </tr>
                    
                        </table>
                    </div>
                    
                
            <details style="margin-top: 16px;">
                <summary style="
                    padding: 10px;
                    background: #f8fafc;
                    border-radius: 8px;
                    font-weight: 600;
                    font-size: 12px;
                    list-style: none;
                    cursor: pointer;
                    color: #64748b;
                    border: 1px solid #e2e8f0;
                ">
                    üìÑ View Full RNS Text
                </summary>
                <div style="
                    margin-top: 8px;
                    padding: 14px;
                    background: #f1f5f9;
                    border-radius: 8px;
                    font-family: 'Courier New', monospace;
                    font-size: 11px;
                    line-height: 1.5;
                    color: #475569;
                    max-height: 300px;
                    overflow-y: auto;
                    white-space: pre-wrap;
                    word-wrap: break-word;
                ">
23 Nov 2023 07:00
RNS Number : 3824U
Cambridge Nutritional Sciences PLC
23 November 2023
CAMBRIDGE NUTRITIONAL SCIENCES PLC
("CNS" or the "Company" or the "Group")
Half-Year Report
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Strong revenue increase, 2022 sales backlog cleared and FoodPrint¬Æ
yields significantly improved;
Company firmly on track to meet market expectations for the full year
CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces its unaudited interim results for the six months ended 30 September 2023
.
H1 Financial Highlights:
¬∑
Revenue increased 44% to ¬£4.9m (H1 2022: ¬£3.4m).
¬∑
Gross margin increased to 62.7% (H1 2022: 54.0%), largely due to production efficiencies & product mix
¬∑
Adjusted EBITDA1 ¬£0.0m (H1 2022: restated loss ¬£0.4m).
¬∑
Loss before tax ¬£0.7m (H1 2022: restated loss ¬£0.8m).
¬∑
Loss on discontinued operations ¬£ Nil (H1 2022: restated loss of ¬£1.2m).
¬∑
Cash balance ¬£4.4m (H1 2022: ¬£2.7m).
Operational Highlights:
¬∑
Strong performance in operations with FoodPrint¬Æ yields significantly improved.
¬∑
First USA laboratory commercialising FoodPrint¬Æ.
¬∑
MyHealth Tracker roll out expanding to all UK customers and installed in one European country.
¬∑
Microbiome menu expansion moving into trial phase in UK.
¬∑
Creation of a continuous improvement function to build on the work done by Chartwell Consulting.
¬∑
Appointment of new independent Non-Executive Director, Carolyn Rand.
¬∑
Successful name change to Cambridge Nutritional Sciences Plc (AIM: CNSL), better reflecting the standalone business.
Outlook:
¬∑
Company is on track to meet market expectations for the full year.
¬∑
Healthy pipeline of sales, adding sales from three new countries with demand expanding via our scientific educational programmes.
¬∑
MyHealth Tracker UK customer roll out expected in H2; international roll out to commence in FY25.
¬∑
Well-funded to deliver on our strategic objectives.
¬∑
Further USA Laboratories expected to commercialise FoodPrint¬Æ in FY25.
¬∑
The Board remains confident that the Company has a compelling case regarding the dispute with DHSC but there have been no material developments. The Board continues to vigorously pursue its substantial counterclaim for losses incurred.
1
Adjusted for exceptional items, amortisation of intangible assets and share based payment charges.
Commenting on the results, Jag Grewal, Chief Executive officer, said:
"The first half of this year delivered encouraging performance in both financial and operational terms. It is particularly reassuring to see improvements in the operational side of the business yielding tangible results. We continue to build a new foundation as a standalone business and believe we have the right strategy and vision to build on a leadership position in the exciting market of personalised health and nutrition."
Investor presentation
Simon Douglas, Chair, and Jag Grewal, CEO, will provide a live presentation relating to the¬†Interim Results¬†via the Investor Meet Company platform today at 4:30pm GMT. The presentation is open to all existing and potential shareholders.
Investors can sign up to Investor Meet Company for free and add to meet¬†Cambridge Nutritional Sciences PLC¬†via:
https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register-investor
The investor presentation will be available later this morning on the Company website:
https://www.cnsplc.com/financials/presentations
The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014
Contacts:
Cambridge Nutritional Sciences PLC
www.cnsplc.com
Jag Grewal, Chief Executive
via Walbrook PR
Cavendish Capital Markets Limited
Tel: 020 7220 0500
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
Walbrook PR Limited
Tel: 020 7933 8780 or
omega@walbrookpr.com
Paul McManus / Charlotte Edgar
Mob: 07980 541 893 / Mob: 07884 664 686/
Sam Allen
Mob: 07502 558 258
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.
Chair's Statement
Overview
I am pleased to report that we have made a positive start over the first half of this fiscal year. The production challenges previously reported have been overcome and we have now cleared the sales backlog. We are delivering on our strategic objectives and have now established ourselves as a standalone business focused on Health and Nutrition under our new name of Cambridge Nutritional Sciences Plc ('CNS'). The market we serve remains exciting with a significant opportunity for global growth as more people are aware of their personalised health and its link to nutrition.
Financial Performance
Revenue increased 44.0% to ¬£4.9m (H1: ¬£3.4m) helped by both production and yield improvements of FoodPrint¬Æ enabling the clearing of the sales backlog arising from the FY23 production issues. FY24 revenue is expected to be in line with expectations.
Revenue by product group:
¬ß
Sales of FoodPrint¬Æ increased 47.0% to ¬£3.3m (H1 2022: ¬£2.2m)
¬ß
Sales of Food Detective¬Æ were ¬£0.7m in line with the prior year
¬ß
CNS Lab and other sales were up 97.0% to ¬£0.9m (H1 2022: ¬£0.4m)
Gross profit from operations increased to ¬£3.1m (H1 2022: ¬£1.9m) with an improved gross margin percentage of 62.7% (H1 2022: 54.0%). The increase in margin principally reflects the improvements in production yields as well as a higher proportion of high margin FoodPrint¬Æ tests in the product mix. The Board is confident that Food Print¬Æ margins will continue at this improved level in H2 FY24 as the Company benefits from the enhanced operational efficiencies.
Overheads increased by 31% to ¬£3.5m (H1 2022: restated ¬£2.7m). ¬£0.3m from underlying period growth with the balance related to one-time investment of the operational improvement project and business realignment, and a ¬£0.1m FX headwind.
The Group continues to consider EBITDA and adjusted EBITDA (adjusted for exceptional items and share-based payments) as being the appropriate measures of profitability being aligned with the cash generating activities of the business. The adjusted EBITDA was ¬£0.0m (H1 2022: loss of ¬£0.2m). The ¬£0.3m adjustment for exceptional items is related to realigning the group for the future.
The cash balance on 30 September 2023 was ¬£4.4m (H1 2022: ¬£2.7m, 31 March 2023: ¬£5.1m).
Operational Update
Earlier in the year we were pleased to report that the production challenges announced have been resolved,
after working
with industry specialists, Chartwell Consulting ('Chartwell') over the six-month period to embed new working processes. The result is that FoodPrint¬Æ production yields have increased and are significantly higher than the preceding six months, demonstrating the effectiveness of the
improved measures.
These newly implemented measures, alongside management changes, have allowed us to address the order backlog and the market's demand for food sensitivity tests remains strong. As part of this process, and in our drive to constantly seek operational improvements, we now have a permanent continuous improvement function in our operations department to promote further efficiency and productivity across the business.
Historically the business support systems were delivered from the group in Scotland, and we are now in the final steps post separating the business. Operationally we continue to evaluate alternative technologies for our flagship product, FoodPrint¬Æ, to ensure the long-term future of the product.
Strategic Priorities
The MyHealthTracker App ('the App'), announced in March 2023, is designed for use on both iOS and Android platforms and will give us a direct connection to customers. It has been rolled out across the UK with selected health care professionals and their customers and initial feedback shows that the product has been well received by both groups. We are looking to release the product more broadly in the UK in early 2024. During the period we also supported initial installation of the digital platform in one European country, and we look forward to introducing the App into more geographies during 2024 and beyond.
As we announced at the beginning of 2023, FoodPrint¬Æ was installed in our first laboratory in the USA and following approvals is now live and actively commercialising FoodPrint¬Æ. Further expansion into the USA is planned, with validation and approvals currently taking place with two other laboratories in the region.
We saw robust growth in our UK market, which is serviced by our own testing laboratory, CNSLab. Sales grew by 97%, driven by both practitioner-based business as well as direct consumer demand serviced by our white-label partners.
Our menu expansion into Microbiome testing is progressing
with a UK based trial in conjunction with a test report provider which will allow us to assess the market feedback and requirements to further define the product offering in what is a fast-evolving area.
Dispute with the DHSC
There is no further progress to report in our dispute with the Department of Health and Social Care ('DHSC'). The Board continues to vigorously pursue its substantial counterclaim for losses incurred towards the DHSC, as a direct result of its failure to licence the necessary intellectual property to permit the contract to move forward and their failure to notify the Group of their inability to do so in a timely manner. The Board remains confident that the Company has a compelling case.
Current Trading and Outlook
We are pleased with progress over the first half of the fiscal year as the Company builds a solid foundation from which it can continue to grow. H2 is expected to remain strong, although in the absence of any further backlog to fulfill, is expected to be slightly lower than H1 FY24 with the full year's revenue expected to be in line with market expectations. The investment for the final steps in the
separation of the business from the historical group will be completed during FY25. We
will continue with our plans of expanding into the USA market and adding value to the customer base with two other laboratories in the region working on the validation and approval of the FoodPrint test in readiness for launch in early FY25. The MyHealth Tracker roll out in the UK will be finalised in Q4 FY24 and a further phased roll out is planned for FY25.
The Board's expectations are that the market conditions remain good and that we are well capitalised and in a strong position to grow as a standalone business.
Simon Douglas
Non-Executive Chair
Consolidated Statement of¬†Comprehensive Income
for the six months ended 30 September 2023
As restated*
6 months ended.
30 September 2023
6 months ended.
30 September 2022
12 months ended.
31 March 2023
Note
¬£'000
¬£'000
¬£'000
Continuing operations
Revenue
3
4,934
3,434
7,546
Cost of sales
(1,841)
(1,581)
(4,001)
Gross profit
3,093
1,853
3,545
Administration costs
(2,746)
(1,959)
(4,755)
Selling and marketing costs
(790)
(730)
(1,530)
Other income
51
-
25
Operating loss before exceptional items
(392)
(836)
(2,715)
Exceptional items
(294)
-
(524)
Operating loss after exceptional items
(686)
(836)
(3,239)
Finance costs
4
(12)
(6)
(13)
Loss before taxation
(698)
(842)
(3,252)
Tax credit
5
-
-
80
Loss for the period from continuing operations
(698)
(842)
(3,172)
Discontinued operations
Loss after tax for the period from discontinued operations
6
-
(1,245)
(688)
Loss for the period
(698)
(2,087)
(3,860)
Other comprehensive (losses)/income to be reclassified to profit and loss in subsequent periods
Exchange differences on translation of foreign operations
(3)
22
(15)
Other comprehensive income for the period
(3)
22
(15)
Total comprehensive lossesfor the period
(701)
(2,065)
(3,875)
Earnings per share (EPS)
Basic and diluted EPS on loss for the period
7
(0.3)p
(0.9)p
(1.7)p
Earnings per share for continuing operations
Basic and diluted EPS on loss for the period from continuing operations
7
(0.3)p
(0.4)p
(1.4)p
* See note 2 for details regarding the restatement.
Consolidated Balance Sheet
as at 30 September 2023
30 September 2023
30 September 2022
31 March 2023
Note
¬£'000
¬£'000
¬£'000
ASSETS
Non-current assets
Intangibles
8
4,313
4,556
4,525
Property, plant, and equipment
9
515
1,062
567
Right of use assets
9
177
62
21
Deferred taxation
994
1,120
997
Total non-current assets
5,999
6,800
6,110
Current assets
Inventories
1,073
1,074
777
Trade and other receivables
2,290
6,544
2,403
Cash and cash equivalents
4,396
2,712
5,115
Total current assets
7,759
10,330
8,295
Assets held for sale
-
-
-
Total assets
13,758
17,130
14,405
EQUITY AND LIABILITIES
Equity
Share capital
10,244
10,244
10,244
Share premium
25,072
25,100
25,072
Retained deficit
(25,974)
(23,534)
(25,319)
Translation reserve
(49)
(8)
(46)
Total equity
9,293
11,802
9,951
Liabilities
Non-current liabilities
Long-term borrowings
3
35
19
Lease liabilities
77
-
-
Deferred income
2,500
2,500
2,500
Total non-current liabilities
2,580
2,535
2,519
Current liabilities
Short-term borrowings
33
31
32
Lease liabilities
101
69
23
Trade and other payables
1,452
2,282
1,525
Total current liabilities
1,586
2,382
1,580
Liabilities directly associated with assets held for sale
299
411
355
Total liabilities
4,465
5,328
4,454
Total equity and liabilities
13,758
17,130
14,405
* See note 2 for details regarding the restatement.
Consolidated Statement of¬†Changes in Equity
for the six months ended 30 September 2023
Share
Share
Retained
Translation
capital
premium
deficit
reserve
Total
¬£'000
¬£'000
¬£'000
¬£'000
¬£'000
Balance at 31 March 2022
8,044
25,340
(21,537)
(31)
11,816
Loss for the period to 30 September 2022
-
-
(2,087)
-
(2,087)
Other comprehensive losses - net exchange adjustments
-
-
-
23
23
Total comprehensive (losses)/income for the period
-
-
(2,087)
23
(2,064)
Issue of share capital for cash consideration
2,200
-
-
-
2,200
Expenses in connection with share issue
-
(240)
-
-
(240)
Share-based payments
-
-
90
-
90
Balance at 30 September 2022
10,244
25,100
(23,534)
(8)
11,802
Loss for the period to 31 March 2023
-
-
(1,773)
-
(1,773)
Other comprehensive income - net exchange adjustments
-
-
-
(38)
(38)
Total comprehensive losses for the period
-
-
(1,773)
(38)
(1,811)
Expenses in connection with share issue
-
(28)
-
-
(28)
Share-based payments
-
-
(12)
-
(12)
Balance at 31 March 2023
10,244
25,072
(25,319)
(46)
9,951
Loss for the period to 30 September 2023
-
-
(698)
-
(698)
Other comprehensive income - net exchange adjustments
-
-
-
(3)
(3)
Total comprehensive (losses)/income for the period
-
-
(698)
(3)
(701)
Share-based payments
-
-
43
-
43
Balance at 30 September 2023
10,244
25,072
(25,974)
(49)
9,293
* See note 2 for details regarding the restatement.
Consolidated Cash Flow Statement
for the six months ended 30 September 2023
As restated*
6 months ended
30 September 2023
6 months ended
30 September 2022
12 months ended
31 March 2023
¬£'000
¬£'000
¬£'000
Cash flows generated from operations
Loss for the year from continuing operations
(698)
(842)
(3,172)
Loss for the year from discontinued operations
-
(1,245)
(688)
Adjustments for:
?Depreciation
108
120
219
?Amortisation of intangible assets
219
225
372
?Impairment and derecognition of intangible assets
-
15
15
Impairment of assets related to aborted Ely relocation
-
-
399
?Impairment loss recognised on the remeasurement to fair value
-
176
176
?Share-based payments
43
90
78
?Taxation
-
-
(380)
?Finance costs
12
21
16
Cash outflow from operating activities before working capital movement
(316)
(1,440)
(2,965)
Decrease in trade and other receivables
113
672
812
(Increase)/decrease in inventories
(296)
(168)
128
Decrease in trade and other payables
(73)
(843)
(1,466)
Movement in grants
-
(4)
(139)
Taxation received
-
-
478
Cash outflow from operating activities
(572)
(1,783)
(3,152)
Investing activities
Finance income
-
-
19
Income from sale of CD4 business
-
1,315
5,315
Purchase of property, plant, and equipment
(10)
(25)
(25)
Purchase of intangible assets
(7)
(51)
(128)
Net cash (outflow)/inflow in investing activities
(17)
1,239
5,181
Financing activities
Finance costs
(1)
-
(1)
Proceeds from issue of share capital
-
2,200
2,200
Expenses in connection with share issue
-
(240)
(268)
Principal portion of asset finance payments
(71)
(243)
(314)
Interest portion of asset finance payments
(7)
(16)
(25)
Principal portion of lease liability payments
(47)
(46)
(97)
Interest portion of lease liability payments
(4)
(5)
(9)
Net cash (outflow)/inflow from financing activities
(130)
1,650
1,486
Net (decrease)/increase in cash and cash equivalents
(719)
1,106
3,515
Effects of exchange rate movements
-
1
(5)
Cash and cash equivalents at beginning of period
5,115
1,605
1,605
Cash and cash equivalents at end of the period
4,396
2,712
5,115
* See note 2 for details regarding the restatement.
Notes to the Interim Report
for the six months ended 30 September 2023
1. BASIS OF PREPARATION
For the purpose of preparing the 31 March 2023 annual financial statements the Directors used IFRS as adopted by the EU and in accordance with the AIM Rules issued by the London Stock Exchange. In preparing these interim financial statements, the accounting policies used in the Group's Annual Report for the year ended 31 March 2023 have been applied consistently. The Group has not applied IAS 34
Interim Financial Reporting
, which is not mandatory for AIM companies, in the preparation of these interim financial statements.
The interim financial statements are unaudited. The information shown in the consolidated balance sheet as at 30 September 2023 does not constitute statutory accounts as defined in Section 435 of the Companies Act 2006 and the information in respect of the year ended 31 March 2023 has been extracted from the Group's 2023 Annual Report which has been filed with the Registrar of Companies. The report of the auditors on the financial statements contained within the Group's 2023 Annual Report was unqualified and did not contain a statement under sections 498 (2) and 498 (3) of Chapter 3, Part 16 of the Companies Act 2006. These interim financial statements were approved by the Board of Directors on 22 November 2023.
2. RESTATEMENT OF COMPARATIVES
Group
Discontinued operations
Following a review of administration costs, ¬£186,000 of credits applicable to discontinued operations have been identified as being incorrectly applied to continuing operations as reported in the interim results reported for the six months ended 31 September 2022. This does not affect the results reported in the annual report for the year to 31 March 2023.
The effect of the restatements noted above on the consolidated statement of comprehensive income as at 30 September 2022 is as follows:
As reported
Restatement
As restated
30 September 2022
30 September 2022
30 September 2022
¬£'000
¬£'000
¬£'000
Continuing operations
Revenue
3,434
-
3,434
Cost of sales
(1,581)
-
(1,581)
Gross profit
1,853
-
1,853
Administration costs
(1,773)
(186)
(1,959)
Selling and marketing costs
(730)
-
(730)
Other income
-
-
-
Operating loss before exceptional items
(650)
(186)
(836)
Exceptional items
-
-
-
Operating loss after exceptional items
(650)
(186)
(836)
Finance costs
(6)
-
(6)
Loss before taxation
(656)
(186)
(842)
Tax credit/(expense)
-
-
-
Loss for the period from continuing operations
(656)
(186)
(842)
Discontinued operations
Loss after tax for the period from discontinued operations
(1,431)
186
(1,245)
Loss for the period
(2,087)
-
(2,087)
Other comprehensive income to be reclassified to profit and loss in subsequent periods
Exchange differences on translation of foreign operations
22
-
22
Other comprehensive income for the period
22
-
22
Total comprehensive losses for the period
(2,065)
-
(2,065)
Earnings per share (EPS)
Basic and diluted EPS on loss for the period
(0.3)p
-
(0.3)p
Earnings per share for continuing operations
Basic and diluted EPS on loss for the period from continuing operations
(0.3)p
(0.1)p
(0.4)p
3. SEGMENT INFORMATION
Following the withdrawal from COVID-19 products and the decision taken in March 2022 to dispose of the CD4 business, the sale of which was completed on 31 July 2022, the only remaining division is Health and Nutrition. The Global Health division specialised in the research, development, production, and marketing of kits to aid the diagnosis of infectious diseases, including COVID-19.
The Health and Nutrition division specialises in the research, development, and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis to the general public, clinics, and health professionals.
The Corporate segment consists of centralised corporate costs which are not allocated to the trading activities of the Group.
Inter segment transfers or transactions are entered into under the normal commercial conditions that would be available to unrelated third parties.
Business segment information
Health and
Nutrition
Corporate
Total
6 months to 30 September 2023
¬£'000
¬£'000
¬£'000
Revenue
5,062
-
5,062
Inter-segment revenue
(128)
-
(128)
Total revenue
4,934
-
4,934
Cost of sales
(1,841)
-
(1,841)
Gross profit
3,093
-
3,093
Operating costs
(2,739)
(746)
(3,485)
Operating profit/(loss) before exceptional items
354
(746)
(392)
Exceptional items
(151)
(143)
(294)
Operating profit/(loss) after exceptional items
203
(889)
(686)
Depreciation
108
-
108
Amortisation
219
-
219
EBITDA
530
(889)
(359)
Exceptional items
151
143
294
Share-based payment charges
-
17
17
Adjusted EBITDA
681
(729)
(48)
Share-based payment charges
-
(17)
(17)
Depreciation
(108)
-
(108)
Amortisation
(219)
-
(219)
Net finance costs
(12)
-
(12)
Exceptional costs
(151)
(143)
(294)
Profit/(loss) before tax
191
(889)
(698)
Exceptional items
151
143
294
Share-based payment charges
-
17
17
Amortisation
61
-
61
Adjusted profit/(loss) before tax
403
(729)
(326)
3. SEGMENT INFORMATION (CONTINUED)
As restated*
Health and
As restated*
Nutrition
Corporate
Total
6 months to 30 September 2022
¬£'000
¬£'000
¬£'000
Revenue
3,533
-
3,533
Inter-segment revenue
(99)
-
(99)
Total revenue
3,434
-
3,434
Cost of sales
(1,581)
-
(1,581)
Gross profit
1,853
-
1,853
Operating costs
(2,133)
(556)
(2,689)
Operating loss before exceptional items
(280)
(556)
(836)
Exceptional items
-
-
-
Operating loss after exceptional items
(280)
(556)
(836)
Depreciation
106
-
106
Amortisation
225
-
225
EBITDA
51
(556)
(505)
Share-based payment charges
-
90
90
Adjusted EBITDA
51
(466)
(415)
Share-based payment charges
-
(90)
(90)
Depreciation
(106)
-
(106)
Amortisation
(225)
-
(225)
Net finance costs
(6)
-
(6)
Loss before tax
(286)
(556)
(842)
Share-based payment charges
-
90
90
Amortisation
49
-
49
Adjusted loss before tax
(237)
(466)
(703)
* See note 2 for details regarding the restatement.
The adjusted profit/(loss) before taxation is a key measure of the Group's trading performance used by the Directors. The reported numbers are non-GAAP measures
3
. SEGMENT INFORMATION (CONTINUED)
6 months to
30 September 2023
6 months to
30 September 2022
¬£'000
¬£'000
Revenues
UK
830
423
Rest of Europe
1,167
1,125
North America
1,031
606
South/Central America
243
141
India
282
286
Asia
874
651
Africa and the Middle East
507
202
4,934
3,434
6 months to
30 September 2023
6 months to
30 September 2022
inc/(dec)
¬£'000
¬£'000
%
FoodPrint
¬Æ
3,284
2,239
47%
Food Detective
¬Æ
732
706
4%
CNS laboratory service
829
420
97%
Food ELISA/other
89
69
28%
4,934
3,434
44%
4.
FINANCE COSTS
6 months to
30 September 2023
6 months to
30 September 2022
Continuing operations
¬£'000
¬£'000
Interest payable on bank overdraft
1
-
Interest payable on lease liabilities
4
4
Interest on hire purchase and asset finance arrangements
7
2
12
6
5. TAXATION
6 months to
30 September 2023
6 months to
30 September 2022
Continuing operations
¬£'000
¬£'000
Tax credited in the income statement
Current tax - current year
-
-
Current tax - prior year adjustment
-
-
Deferred tax - current year
-
-
Deferred tax - prior year adjustment
-
-
-
-
Reconciliation of total tax credit
Factors affecting the tax credit for the period:
¬£'000
¬£'000
Loss taxable
(672)
(656)
Effective rate of taxation
19%
19%
Loss before tax multiplied by the effective rate of tax
(128)
(125)
Effects of:
Deferred tax asset not recognised
128
125
Tax credit for the period
-
-
6. DISCONTINUED OPERATIONS
As restated*
6 months to
30 September 2022
¬£'000
Revenue
657
Cost of sales
(567)
Gross profit/(loss)
90
Administration costs
(1,175)
Selling and marketing costs
-
Other income
4
Operating loss before exceptional items
(1,081)
Exceptional items
-
Operating loss after exceptional items
(1,081)
Finance costs
(15)
Impairment loss recognised on the remeasurement to fair value less costs to sell
(149)
Loss before taxation
(1,245)
Tax
-
Loss for the period from discontinued activities
(1,245)
* See note 2 for details regarding the restatement.
Adjusted loss before taxation
6 months to
30 September 2022
¬£'000
Loss for the period from discontinued activities
(1,245)
Exceptional items
-
Amortisation of intangible assets
7
Adjusted loss for the period from discontinued activities
(1,238)
Earnings per share
6 months to
30 September 2022
¬£'000
Basic, loss for the period from discontinued operations
(0.5)p
Diluted, loss for the period from discontinued operations
(0.5)p
Adjusted, loss for the period from discontinued operations
(0.5)p
6. DISCONTINUED OPERATIONS (CONTINUED)
The major classes of assets and liabilities of the Global Health business as at 30 September 2023 are, as follows:
30 September 2023
30 September 2022
¬£'000
¬£'000
Assets
Property, plant, and equipment
-
-
Total assets held for sale
-
-
Liabilities
Borrowings
(299)
(411)
Total liabilities directly associated with the assets held for sale
(299)
(411)
Net liabilities directly associated with the disposal group
(299)
(411)
The property, plant and equipment relate primarily to COVID-19 plant and equipment no longer used in the business which have all been written down to zero value, the liabilities relate to the hire purchase on these assets.
7. EARNINGS PER SHARE
As restated*
6 months to
30 September 2023
6 months to
30 September 2022
¬£'000
¬£'000
Loss attributable to equity holders of the Group
Continuing operations
(698)
(842)
Discontinued operations
-
(1,245)
Loss attributable to equity holders of the Group for basic earnings
(698)
(2,087)
2023
2022
Continuing operations
Number
Number
Weighted average number of shares
237,685,180
225,443,711
Share options
-
-
Diluted weighted average number of shares
237,685,180
225,443,711
* See note 2 for details regarding the restatement.
The number of shares in issue at the period end was 237,685,180.
Basic earnings per share are calculated by dividing profit for the year attributable to ordinary equity holders of the Group by the weighted average number of ordinary shares outstanding during the year.
Diluted earnings per share are calculated by dividing the loss attributable to ordinary equity holders of the Group by the weighted average number of ordinary shares outstanding during the year plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. Diluting events are excluded from the calculation when the average market price of ordinary shares is lower than the exercise price.
Adjusted earnings per share on loss for the period
The Group presents adjusted earnings per share which is calculated by taking adjusted loss before taxation and adding the tax credit in order to allow shareholders to understand better the elements of financial performance in the year, so as to facilitate comparison with prior periods and to assess better trends in financial performance.
6 months to
30 September 2023
6 months to
30 September 2022
¬£'000
¬£'000
Loss attributable to equity holders of the Group
(698)
(2,087)
Exceptional items
294
-
Amortisation of intangible assets
61
56
Share-based payment charges
17
90
Adjusted loss attributable to equity holders of the Group
(326)
(1,941)
Adjusted loss for the year - continuing operations
The reported numbers are non-GAAP measure
6 months to
30 September 2023
6 months to
30 September 202
2
¬£'000
¬£'000
(Loss)/profit for the period from continuing operations
(698)
(842)
Exceptional items
294
-
Amortisation of intangible assets
61
49
Share-based payment charges
17
90
Adjusted (loss)/profit for the period from continuing operations
(326)
(703)
* See note 2 for details regarding the restatement.
7. EARNINGS PER SHARE (CONTINUED)
Adjusted EPS on loss for the period
(0.1)p
(0.8)p
Adjusted EPS on loss for the period from continuing operations
(0.1)p
(0.3)p
Adjusted loss before taxation, which is a key measure of the Group's trading performance used by the Directors, is derived by taking statutory loss before taxation and adding back exceptional items, amortisation of intangible assets (excluding development costs) and share-based payment charges.
8. INTANGIBLES
Licences/
Technology
Customer
Development
Goodwill
software
assets
relationships
costs
Total
¬£'000
¬£'000
¬£'000
¬£'000
¬£'000
¬£'000
Cost
At 31 March 2022
3,017
1,634
1,975
100
9,181
15,907
Additions
-
-
-
-
16
16
Additions - internally generated
-
-
-
-
35
35
At 30 September 2022
3,017
1,634
1,975
100
9,232
15,958
Additions
-
50
-
-
50
100
Additions - internally generated
-
-
-
-
(23)
(23)
Reallocated from property, plant, and equipment
-
42
-
-
-
42
At 31 March 2023
3,017
1,726
1,975
100
9,259
16,077
Additions
-
7
-
-
-
7
At 30 September 2023
3,017
1,733
1,975
100
9,259
16,084
Accumulated amortisation
At 31 March 2022
-
1,619
1,440
100
8,003
11,162
Amortisation charge in the period
-
-
49
-
176
225
Impairment charge
-
15
-
-
-
15
At 30 September 2022
-
1,634
1,489
100
8,179
11,402
Amortisation charge in the period
-
10
50
-
87
147
Reallocated from property, plant, and equipment
-
4
-
-
-
4
Currency translation
-
(1)
-
-
-
(1)
At 31 March 2023
-
1,647
1,539
100
8,266
11,552
Amortisation charge in the period
-
12
49
-
158
219
At 30 September 2023
-
1,659
1,588
100
8,424
11,771
Net book value
At 30 September 2023
3,017
74
387
-
835
4,313
At 31 March 2023
3,017
79
436
-
993
4,525
At 30 September 2022
3,017
-
486
-
1,053
4,556
9. FIXED ASSETS
Right of use
Leasehold
Plant and
assets
improvements
machinery
Total
Consolidated
¬£'000
¬£'000
¬£'000
¬£'000
Cost
At 31 March 2022
412
696
2,461
3,569
Additions
-
1
24
25
Currency translation
-
-
1
1
At 30 September 2022
412
697
2,486
3,595
Additions
-
(1)
1
-
Reallocated to intangible assets
-
-
(42)
(42)
At 31 March 2023
412
696
2,445
3,553
Additions
202
-
10
212
Disposals
(412)
-
-
(412)
At 30 September 2023
202
696
2,455
3,353
Accumulated depreciation
At 31 March 2022
306
484
1,535
2,325
Charge in the period
44
-
76
120
Impairment to fair value
-
-
27
27
Currency translation
-
(1)
-
(1)
At 30 September 2022
350
483
1,638
2,471
Charge in the period
41
-
58
99
Impairment to fair value
-
210
189
399
Reallocated to intangible assets
-
-
(4)
(4)
Currency translation
-
1
(1)
-
At 31 March 2023
391
694
1,880
2,965
Charge in the period
46
-
62
108
Disposals
(412)
-
-
(412)
At 30 September 2023
26
694
1,942
2,662
Net book value
At 30 September 2023
177
2
513
692
At 31 March 2023
21
2
565
588
At 30 September 2022
62
214
848
1,124
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com
or visit
www.rns.com
.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy
.
END
IR BRBDBIXDDGXD
                </div>
            </details>
            
            </div>
            
            <div style="
                margin-bottom: 20px;
                padding: 18px;
                background: white;
                border-radius: 14px;
                border: 1px solid #e2e8f0;
                box-shadow: 0 1px 3px rgba(0,0,0,0.05);
            ">
                <div style="display: flex; align-items: center; gap: 10px; margin-bottom: 14px;">
                    <span style="
                        display: inline-flex;
                        align-items: center;
                        justify-content: center;
                        width: 30px;
                        height: 30px;
                        background: linear-gradient(135deg, #ef4444 0%, #ef4444dd 100%);
                        color: white;
                        border-radius: 50%;
                        font-weight: 800;
                        font-size: 15px;
                        box-shadow: 0 2px 8px #ef444440;
                    ">3</span>
                    <div style="font-size: 11px; color: #94a3b8; font-weight: 600; letter-spacing: 0.5px;">
                        RNS ANNOUNCEMENT #3
                    </div>
                </div>
                
                
            <div style="
                background: linear-gradient(135deg, #ef4444 0%, #ef4444dd 100%);
                color: white;
                padding: 14px;
                border-radius: 10px;
                margin-bottom: 16px;
            ">
                <div style="display: flex; align-items: center; gap: 10px; margin-bottom: 8px;">
                    <span style="font-size: 20px;">üìâ</span>
                    <div style="flex: 1;">
                        <div style="font-weight: 700; font-size: 16px;">Notice of Results & Investor Presentation</div>
                        <span style="
                            display: inline-block;
                            background: rgba(255,255,255,0.25);
                            padding: 2px 10px;
                            border-radius: 12px;
                            font-size: 11px;
                            margin-top: 4px;
                            font-weight: 600;
                        ">GROK: 70/100 ‚Ä¢ BEARISH</span>
                    </div>
                </div>
                <div style="font-size: 13px; opacity: 0.95; line-height: 1.4;">
                    FINANCIAL RESULTS: Financial results released | üìâ BEARISH: Poor results likely cause selling. Assess if bottom is in.
                </div>
            </div>
            
                
            <div style="
                display: grid;
                grid-template-columns: repeat(auto-fit, minmax(120px, 1fr));
                gap: 10px;
                margin: 16px 0;
            ">
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">DATE</div>
                    <div style="font-weight: 700; font-size: 13px; color: #0f172a;">31st Jul 2025</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">TIME</div>
                    <div style="font-weight: 700; font-size: 13px; color: #0f172a;">7:00 am</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">SOURCE</div>
                    <div style="font-weight: 700; font-size: 13px; color: #ef4444;">RNS</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">SENTIMENT</div>
                    <div style="font-weight: 700; font-size: 13px; color: #ef4444;">BEARISH</div>
                </div>
            </div>
            
                
                <div style="
                    margin: 16px 0;
                    padding: 14px;
                    background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
                    border-radius: 10px;
                    border-left: 4px solid #ef4444;
                ">
                    <h4 style="
                        font-size: 13px;
                        color: #1e293b;
                        margin-bottom: 12px;
                        font-weight: 700;
                        display: flex;
                        align-items: center;
                        gap: 8px;
                    ">
                        <span style="font-size: 16px;">ü§ñ</span> GROK INTELLIGENCE ANALYSIS
                        <span style="
                            display: inline-block;
                            background: #ef4444;
                            color: white;
                            padding: 2px 8px;
                            border-radius: 10px;
                            font-size: 11px;
                            font-weight: 800;
                        ">70/100</span>
                    </h4>
                    
                    <div style="display: grid; gap: 10px;">
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">EVENT TYPE:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">FINANCIAL RESULTS: Financial results released</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">TRADING VIEW:</div>
                            <div style="font-size: 12px; color: #ef4444; font-weight: 600;">üìâ BEARISH: Poor results likely cause selling. Assess if bottom is in.</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">RISK LEVEL:</div>
                            <div style="font-size: 12px; color: #3b82f6; font-weight: 600;">üîµ NEUTRAL: Balanced or routine update</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">RECOMMENDED:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">üìã HOLD: Monitor for developing patterns in announcements</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">COMPANY HEALTH:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">‚û°Ô∏è STABLE: Mixed signals, normal operations</div>
                        </div>
                    </div>
                </div>
                
                
                    <div style="margin: 16px 0;">
                        <h4 style="font-size: 14px; color: #1e293b; margin-bottom: 10px; font-weight: 700;">üìä Key Data Points:</h4>
                        <table style="width: 100%; border-collapse: collapse; font-size: 13px; background: white; border-radius: 8px; overflow: hidden;">
                            
                    <tr style="border-bottom: 1px solid #e2e8f0;">
                        <td style="padding: 8px; color: #64748b; font-weight: 600; font-size: 12px;">PERSON/ENTITY:</td>
                        <td style="padding: 8px; font-weight: 600; font-size: 12px;">Primary Information</td>
                    </tr>
                    
                        </table>
                    </div>
                    
                
            <details style="margin-top: 16px;">
                <summary style="
                    padding: 10px;
                    background: #f8fafc;
                    border-radius: 8px;
                    font-weight: 600;
                    font-size: 12px;
                    list-style: none;
                    cursor: pointer;
                    color: #64748b;
                    border: 1px solid #e2e8f0;
                ">
                    üìÑ View Full RNS Text
                </summary>
                <div style="
                    margin-top: 8px;
                    padding: 14px;
                    background: #f1f5f9;
                    border-radius: 8px;
                    font-family: 'Courier New', monospace;
                    font-size: 11px;
                    line-height: 1.5;
                    color: #475569;
                    max-height: 300px;
                    overflow-y: auto;
                    white-space: pre-wrap;
                    word-wrap: break-word;
                ">
31 Jul 2025 07:00
RNS Number : 1870T
Cambridge Nutritional Sciences PLC
31 July 2025
Cambridge Nutritional Sciences plc
(the
"Company"
or
"CNSL"
)
Notice of Results & Investor Presentation via Investor Meet Company
Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it will publish its Final Results for the year ended 31 March 2025 on Tuesday, 19 August 2025.
Investor Presentation:
On the same day at 14:30 BST, James Cooper (Chief Executive Officer) and Ajay Patel (Chief Financial Officer) will host a live online presentation via the Investor Meet Company ("IMC") platform to discuss the results.
The presentation is open to all existing and potential shareholders. Questions can be submitted in advance via the IMC dashboard up until 09:00 BST on 18 August 2025, or during the live event.
To register for the event and add Cambridge Nutritional Sciences plc to your watchlist, please visit:
https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register-investor
Shareholders who already follow Cambridge Nutritional Sciences plc on the IMC platform will be automatically invited to the presentation.
Contacts:
Cambridge Nutritional Sciences plc
www.cnsplc.com
Carolyn Rand, Non-Executive Chair
investors@cnsplc.com
James Cooper, Chief Executive Officer
Ajay Patel, Chief Financial Officer
Cavendish Capital Markets Limited
Tel: 020 7220 0500
Geoff Nash / Edward Whiley / (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a
specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com
or visit
www.rns.com
.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy
.
END
NORURVWRVOUBORR
                </div>
            </details>
            
            </div>
            
            <div style="
                margin-bottom: 20px;
                padding: 18px;
                background: white;
                border-radius: 14px;
                border: 1px solid #e2e8f0;
                box-shadow: 0 1px 3px rgba(0,0,0,0.05);
            ">
                <div style="display: flex; align-items: center; gap: 10px; margin-bottom: 14px;">
                    <span style="
                        display: inline-flex;
                        align-items: center;
                        justify-content: center;
                        width: 30px;
                        height: 30px;
                        background: linear-gradient(135deg, #ef4444 0%, #ef4444dd 100%);
                        color: white;
                        border-radius: 50%;
                        font-weight: 800;
                        font-size: 15px;
                        box-shadow: 0 2px 8px #ef444440;
                    ">4</span>
                    <div style="font-size: 11px; color: #94a3b8; font-weight: 600; letter-spacing: 0.5px;">
                        RNS ANNOUNCEMENT #4
                    </div>
                </div>
                
                
            <div style="
                background: linear-gradient(135deg, #ef4444 0%, #ef4444dd 100%);
                color: white;
                padding: 14px;
                border-radius: 10px;
                margin-bottom: 16px;
            ">
                <div style="display: flex; align-items: center; gap: 10px; margin-bottom: 8px;">
                    <span style="font-size: 20px;">üìâ</span>
                    <div style="flex: 1;">
                        <div style="font-weight: 700; font-size: 16px;">Result of AGM</div>
                        <span style="
                            display: inline-block;
                            background: rgba(255,255,255,0.25);
                            padding: 2px 10px;
                            border-radius: 12px;
                            font-size: 11px;
                            margin-top: 4px;
                            font-weight: 600;
                        ">GROK: 70/100 ‚Ä¢ BEARISH</span>
                    </div>
                </div>
                <div style="font-size: 13px; opacity: 0.95; line-height: 1.4;">
                    FINANCIAL RESULTS: Financial results released | üìâ BEARISH: Poor results likely cause selling. Assess if bottom is in.
                </div>
            </div>
            
                
            <div style="
                display: grid;
                grid-template-columns: repeat(auto-fit, minmax(120px, 1fr));
                gap: 10px;
                margin: 16px 0;
            ">
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">DATE</div>
                    <div style="font-weight: 700; font-size: 13px; color: #0f172a;">27th Sep 2024</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">TIME</div>
                    <div style="font-weight: 700; font-size: 13px; color: #0f172a;">11:20 am</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">SOURCE</div>
                    <div style="font-weight: 700; font-size: 13px; color: #ef4444;">RNS</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">SENTIMENT</div>
                    <div style="font-weight: 700; font-size: 13px; color: #ef4444;">BEARISH</div>
                </div>
            </div>
            
                
                <div style="
                    margin: 16px 0;
                    padding: 14px;
                    background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
                    border-radius: 10px;
                    border-left: 4px solid #ef4444;
                ">
                    <h4 style="
                        font-size: 13px;
                        color: #1e293b;
                        margin-bottom: 12px;
                        font-weight: 700;
                        display: flex;
                        align-items: center;
                        gap: 8px;
                    ">
                        <span style="font-size: 16px;">ü§ñ</span> GROK INTELLIGENCE ANALYSIS
                        <span style="
                            display: inline-block;
                            background: #ef4444;
                            color: white;
                            padding: 2px 8px;
                            border-radius: 10px;
                            font-size: 11px;
                            font-weight: 800;
                        ">70/100</span>
                    </h4>
                    
                    <div style="display: grid; gap: 10px;">
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">EVENT TYPE:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">FINANCIAL RESULTS: Financial results released</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">TRADING VIEW:</div>
                            <div style="font-size: 12px; color: #ef4444; font-weight: 600;">üìâ BEARISH: Poor results likely cause selling. Assess if bottom is in.</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">RISK LEVEL:</div>
                            <div style="font-size: 12px; color: #3b82f6; font-weight: 600;">üîµ NEUTRAL: Balanced or routine update</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">RECOMMENDED:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">üìã HOLD: Monitor for developing patterns in announcements</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">COMPANY HEALTH:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">‚û°Ô∏è STABLE: Mixed signals, normal operations</div>
                        </div>
                    </div>
                </div>
                
                
                    <div style="margin: 16px 0;">
                        <h4 style="font-size: 14px; color: #1e293b; margin-bottom: 10px; font-weight: 700;">üìä Key Data Points:</h4>
                        <table style="width: 100%; border-collapse: collapse; font-size: 13px; background: white; border-radius: 8px; overflow: hidden;">
                            
                    <tr style="border-bottom: 1px solid #e2e8f0;">
                        <td style="padding: 8px; color: #64748b; font-weight: 600; font-size: 12px;">PERSON/ENTITY:</td>
                        <td style="padding: 8px; font-weight: 600; font-size: 12px;">Primary Information</td>
                    </tr>
                    
                        </table>
                    </div>
                    
                
            <details style="margin-top: 16px;">
                <summary style="
                    padding: 10px;
                    background: #f8fafc;
                    border-radius: 8px;
                    font-weight: 600;
                    font-size: 12px;
                    list-style: none;
                    cursor: pointer;
                    color: #64748b;
                    border: 1px solid #e2e8f0;
                ">
                    üìÑ View Full RNS Text
                </summary>
                <div style="
                    margin-top: 8px;
                    padding: 14px;
                    background: #f1f5f9;
                    border-radius: 8px;
                    font-family: 'Courier New', monospace;
                    font-size: 11px;
                    line-height: 1.5;
                    color: #475569;
                    max-height: 300px;
                    overflow-y: auto;
                    white-space: pre-wrap;
                    word-wrap: break-word;
                ">
27 Sep 2024 11:20
RNS Number : 0445G
Cambridge Nutritional Sciences PLC
27 September 2024
Cambridge Nutritional Sciences plc
(the
"Company"
or
"CNSL"
)
Result of AGM
Cambridge Nutritional Sciences plc (AIM:CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that at the Annual General Meeting ("AGM") held on 26th September, all resolutions were duly passed.
The results of the AGM will be made available on the Company's website:
https://www.cnsplc.com/investors/company-information
Contacts:
Cambridge Nutritional Sciences plc
www.cnsplc.com
Carolyn Rand Executive Chair
Cavendish Capital Markets Limited
Tel: 020 7220 0500
Geoff Nash / Edward Whiley / (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a
specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com
or visit
www.rns.com
.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy
.
END
RAGSEAFSWELSEFU
                </div>
            </details>
            
            </div>
            
            <div style="
                margin-bottom: 20px;
                padding: 18px;
                background: white;
                border-radius: 14px;
                border: 1px solid #e2e8f0;
                box-shadow: 0 1px 3px rgba(0,0,0,0.05);
            ">
                <div style="display: flex; align-items: center; gap: 10px; margin-bottom: 14px;">
                    <span style="
                        display: inline-flex;
                        align-items: center;
                        justify-content: center;
                        width: 30px;
                        height: 30px;
                        background: linear-gradient(135deg, #ef4444 0%, #ef4444dd 100%);
                        color: white;
                        border-radius: 50%;
                        font-weight: 800;
                        font-size: 15px;
                        box-shadow: 0 2px 8px #ef444440;
                    ">5</span>
                    <div style="font-size: 11px; color: #94a3b8; font-weight: 600; letter-spacing: 0.5px;">
                        RNS ANNOUNCEMENT #5
                    </div>
                </div>
                
                
            <div style="
                background: linear-gradient(135deg, #ef4444 0%, #ef4444dd 100%);
                color: white;
                padding: 14px;
                border-radius: 10px;
                margin-bottom: 16px;
            ">
                <div style="display: flex; align-items: center; gap: 10px; margin-bottom: 8px;">
                    <span style="font-size: 20px;">üìâ</span>
                    <div style="flex: 1;">
                        <div style="font-weight: 700; font-size: 16px;">Notice of AGM & Annual Report</div>
                        <span style="
                            display: inline-block;
                            background: rgba(255,255,255,0.25);
                            padding: 2px 10px;
                            border-radius: 12px;
                            font-size: 11px;
                            margin-top: 4px;
                            font-weight: 600;
                        ">GROK: 55/100 ‚Ä¢ BEARISH</span>
                    </div>
                </div>
                <div style="font-size: 13px; opacity: 0.95; line-height: 1.4;">
                    FINANCIAL RESULTS: Financial results released | üìâ BEARISH: Poor results likely cause selling. Assess if bottom is in.
                </div>
            </div>
            
                
            <div style="
                display: grid;
                grid-template-columns: repeat(auto-fit, minmax(120px, 1fr));
                gap: 10px;
                margin: 16px 0;
            ">
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">DATE</div>
                    <div style="font-weight: 700; font-size: 13px; color: #0f172a;">28th Aug 2025</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">TIME</div>
                    <div style="font-weight: 700; font-size: 13px; color: #0f172a;">7:00 am</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">SOURCE</div>
                    <div style="font-weight: 700; font-size: 13px; color: #ef4444;">RNS</div>
                </div>
                <div style="padding: 10px; background: #f8fafc; border-radius: 8px;">
                    <div style="font-size: 10px; color: #64748b; margin-bottom: 4px; font-weight: 600;">SENTIMENT</div>
                    <div style="font-weight: 700; font-size: 13px; color: #ef4444;">BEARISH</div>
                </div>
            </div>
            
                
                <div style="
                    margin: 16px 0;
                    padding: 14px;
                    background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
                    border-radius: 10px;
                    border-left: 4px solid #ef4444;
                ">
                    <h4 style="
                        font-size: 13px;
                        color: #1e293b;
                        margin-bottom: 12px;
                        font-weight: 700;
                        display: flex;
                        align-items: center;
                        gap: 8px;
                    ">
                        <span style="font-size: 16px;">ü§ñ</span> GROK INTELLIGENCE ANALYSIS
                        <span style="
                            display: inline-block;
                            background: #ef4444;
                            color: white;
                            padding: 2px 8px;
                            border-radius: 10px;
                            font-size: 11px;
                            font-weight: 800;
                        ">55/100</span>
                    </h4>
                    
                    <div style="display: grid; gap: 10px;">
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">EVENT TYPE:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">FINANCIAL RESULTS: Financial results released</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">TRADING VIEW:</div>
                            <div style="font-size: 12px; color: #ef4444; font-weight: 600;">üìâ BEARISH: Poor results likely cause selling. Assess if bottom is in.</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">RISK LEVEL:</div>
                            <div style="font-size: 12px; color: #3b82f6; font-weight: 600;">üîµ NEUTRAL: Balanced or routine update</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">RECOMMENDED:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">üìã HOLD: Monitor for developing patterns in announcements</div>
                        </div>
                        
                        <div style="display: grid; grid-template-columns: 140px 1fr; gap: 8px; align-items: start;">
                            <div style="font-weight: 600; font-size: 11px; color: #64748b;">COMPANY HEALTH:</div>
                            <div style="font-size: 12px; color: #0f172a; font-weight: 600;">‚û°Ô∏è STABLE: Mixed signals, normal operations</div>
                        </div>
                    </div>
                </div>
                
                
                    <div style="margin: 16px 0;">
                        <h4 style="font-size: 14px; color: #1e293b; margin-bottom: 10px; font-weight: 700;">üìä Key Data Points:</h4>
                        <table style="width: 100%; border-collapse: collapse; font-size: 13px; background: white; border-radius: 8px; overflow: hidden;">
                            
                    <tr style="border-bottom: 1px solid #e2e8f0;">
                        <td style="padding: 8px; color: #64748b; font-weight: 600; font-size: 12px;">PERSON/ENTITY:</td>
                        <td style="padding: 8px; font-weight: 600; font-size: 12px;">Primary Information</td>
                    </tr>
                    
                        </table>
                    </div>
                    
                
            <details style="margin-top: 16px;">
                <summary style="
                    padding: 10px;
                    background: #f8fafc;
                    border-radius: 8px;
                    font-weight: 600;
                    font-size: 12px;
                    list-style: none;
                    cursor: pointer;
                    color: #64748b;
                    border: 1px solid #e2e8f0;
                ">
                    üìÑ View Full RNS Text
                </summary>
                <div style="
                    margin-top: 8px;
                    padding: 14px;
                    background: #f1f5f9;
                    border-radius: 8px;
                    font-family: 'Courier New', monospace;
                    font-size: 11px;
                    line-height: 1.5;
                    color: #475569;
                    max-height: 300px;
                    overflow-y: auto;
                    white-space: pre-wrap;
                    word-wrap: break-word;
                ">
28 Aug 2025 07:00
RNS Number : 9111W
Cambridge Nutritional Sciences PLC
28 August 2025
Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Notice of AGM and Annual Report to 31 March 2025
CNSL (AIM: CNSL), the specialist medical diagnostics company focused on delivering a personalised approach to nutrition for better health, confirms that the Notice of Annual General Meeting ('AGM') has been finalised along with the Annual Report and Accounts for the year ended 31 March 2025. The Company's AGM will be held on Thursday 25 September 2025 at 3.00pm at E-space North, 181 Wisbech, Littleport, Ely, CB6 1RA.
The Annual Report will be posted to shareholders next week and will shortly be made available on the Company's website at:
https://www.cnsplc.com/financials/
Contacts:
Cambridge Nutritional Sciences PLC
www.cnsplc.com
James Cooper, Chief Executive Officer
Ajay Patel, Chief Financial Officer
investors@cnsplc.com
Cavendish Capital Markets Limited
Tel: 020 7220 0500
Geoff Nash / Edward Whiley / (Corporate Finance)
Nigel Birks / Harriet Ward (Sales and ECM)
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is the specialist medical diagnostics company focused on delivering a personalised approach to nutrition for better health.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com
or visit
www.rns.com
.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy
.
END
NOAEAAPXALSSEFA
                </div>
            </details>
            
            </div>
            
            </div>
            <div style="
                margin-top: 20px;
                padding: 14px 16px;
                background: linear-gradient(135deg, #fef3c7 0%, #fde68a 100%);
                border-radius: 10px;
                font-size: 12px;
                color: #78350f;
                border-left: 3px solid #f59e0b;
                display: flex;
                align-items: flex-start;
                gap: 10px;
            ">
                <span style="font-size: 16px; margin-top: 2px;">üéØ</span>
                <div style="line-height: 1.5;">
                    <strong style="display: block; margin-bottom: 4px;">Trader-Focused Analysis:</strong>
                    Each RNS includes sentiment classification, key data extraction, and trading context. 
                    Color-coded badges indicate bullish (green), bearish (red), or neutral (blue) signals.
                    <strong style="margin-top: 6px; display: block; font-size: 10px; opacity: 0.8;">
                    ‚ö†Ô∏è This is analysis of regulatory news for informational purposes. Not investment advice.
                    </strong>
                </div>
            </div>
        </div>
        
        <style>
            @keyframes slideDown {
                from {
                    opacity: 0;
                    transform: translateY(-10px);
                }
                to {
                    opacity: 1;
                    transform: translateY(0);
                }
            }
            details[open] > summary {
                background: linear-gradient(135deg, #eff6ff 0%, #f0f9ff 100%) !important;
                border-left-color: #0369a1 !important;
            }
            summary::-webkit-details-marker {
                display: none;
            }
        </style>
        

        <!-- Footer -->
        <div class="footer">
            Report generated: 2026-01-12 ‚Ä¢ CrashDash APEX Engine<br>
            <strong>‚ñ≥ Not financial advice. Do your own research.</strong>
        </div>

    </div>
</body>
</html>